Trinity Biotech (TRIB) Enterprise Value Growth (5y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.11% |
| Jun 30, 2025 | 36.46% |
| Dec 31, 2024 | 20.13% |
| Sep 30, 2024 | 62.34% |
| Jun 30, 2024 | 26.09% |
| Mar 31, 2024 | 62.25% |
| Dec 31, 2023 | 33.73% |
| Sep 30, 2023 | 28.96% |
| Jun 30, 2023 | 24.17% |
| Mar 31, 2023 | 69.50% |
| Dec 31, 2022 | 40.73% |
| Sep 30, 2022 | 37.42% |
| Jun 30, 2022 | 19.51% |
| Mar 31, 2022 | 19.46% |
| Dec 31, 2021 | 19.60% |
| Sep 30, 2021 | 22.44% |
| Jun 30, 2021 | 19.55% |
| Mar 31, 2021 | 23.15% |
| Dec 31, 2020 | 22.40% |
| Sep 30, 2020 | 31.69% |
| Jun 30, 2020 | 32.40% |
| Mar 31, 2020 | -12.50% |
| Dec 31, 2019 | -12.50% |
| Sep 30, 2019 | -22.90% |
| Jun 30, 2019 | -2.29% |
| Mar 31, 2019 | -12.23% |
| Dec 31, 2018 | -6.29% |
| Sep 30, 2018 | -5.89% |
| Jun 30, 2018 | 5.13% |
| Mar 31, 2018 | 4.65% |
| Dec 31, 2017 | -4.11% |
| Sep 30, 2017 | -0.70% |
| Jun 30, 2017 | -0.93% |
| Mar 31, 2017 | -3.32% |
| Dec 31, 2016 | -1.63% |
| Sep 30, 2016 | -7.47% |
| Jun 30, 2016 | -3.52% |
| Mar 31, 2016 | -11.94% |
| Dec 31, 2015 | -11.94% |
| Sep 30, 2015 | -17.07% |
| Jun 30, 2015 | -16.93% |
| Mar 31, 2015 | -7.44% |
| Dec 31, 2014 | -19.37% |
| Sep 30, 2014 | -17.59% |
| Jun 30, 2014 | -34.16% |
| Mar 31, 2014 | -22.31% |